Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:1429-1437, doi:10.1016/j.jacc.2007.11.073
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zohlnhöfer, D.
Right arrow Articles by Kastrati, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zohlnhöfer, D.
Right arrow Articles by Kastrati, A.
Related Collections
Right arrowRelated Articles

Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor for Myocardial Recovery After Acute Myocardial Infarction

A Meta-Analysis

Dietlind Zohlnhöfer, MD*,*, Alban Dibra, MD*, Tobias Koppara, MD*, Antoinette de Waha, MD*, Rasmus Sejersten Ripa, MD{dagger}, Jens Kastrup, MD{dagger}, Marco Valgimigli, MD, PhD{ddagger}, Albert Schömig, MD* and Adnan Kastrati, MD*

* Deutsches Herzzentrum, Technische Universität München, Munich, Germany
{dagger} Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark
{ddagger} Cardiovascular Institute, University of Ferrara, Ferrara, Italy.


Figure 1
View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 The Effect of Stem Cell Mobilization by G-CSF on Change of Left Ventricular Ejection Fraction

Compared with control conventional treatment, stem cell mobilization by G-CSF had no additional beneficial effect on change in left ventricular function at follow-up as shown by the weighted mean difference for change in left ventricular ejection fraction between treatment and control groups in individual trials. FIRSTLINE-AMI = Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction trial; G-CSF = granulocyte colony-stimulating factor; G-CSF-STEMI = Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction trial; MAGIC Cell 1 = Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion 1 trial; REVIVAL-2 = Regenerate Vital Myocardium by Vigorous Activation of Bone Marrow Stem Cells trial; STEMMI = Stem Cells in Myocardial Infarction trial.

 

Figure 2
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 The Effect of G-CSF on Left Ventricular Ejection Fraction at Follow-Up

Compared with control groups, G-CSF had no beneficial effect on left ventricular function at follow-up as shown by the weighted mean difference of left ventricular ejection fraction at follow-up between treatment and control groups. Abbreviations as in Figure 1.

 

Figure 3
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 The Effect of Stem Cell Mobilization on Angiographic Restenosis

Stem cell mobilization by G-CSF had no effect on angiographic restenosis rate as shown by the odds ratios for angiographically assessed binary restenosis. Abbreviations as in Figure 1.

 

Figure 4
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 The Effect of G-CSF on Target Vessel Revascularization

The G-CSF therapy had no effect on target vessel revascularization as shown by the odds ratios for target vessel revascularization. Abbreviations as in Figure 1.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement